Back

Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice

31 August 2024 (07:55 - 08:40)
Organised by: Logo
Congress Presentation Part of: Drugs, devices, and multidisciplinary care in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mohammad Wasef

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Nationwide analysis of in-hospital mortality and renal infarction trends following cardiac output assist device placement from 2017 to 2020
Doctor A. Balaji (Brooklyn, US)
Abstract Slides
Presentation thumbnail
Beating the clock: the impact of heart failure duration on CRT efficacy
Mr E. Grama (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Optimizing aldosterone receptor antagonist therapy by sodium zirconium cyclosilicate in heart failure - OPRA-HF trial
Doctor C. Basic (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial
Miss N. Nouhravesh (Durham, US)
Abstract Slides
Presentation thumbnail
Echocardiographic evaluation of cardiac remodelling in a cohort of patients with heart failure and reduced ejection fraction treated with dapagliflozin
Doctor J. Bonini (Ferrara, IT)
Abstract Slides

Access the full session

Session thumbnail
Drugs, devices, and multidisciplinary care in heart failure

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Implications of levels of hyperkalemia in the risk of renin-angiotensin-aldosterone system inhibitors interruption/down-titration and mortality in patients with chronic cardiovascular conditions
thumbnail
Congress Presentation
A multidisciplinary clinical dialogue: optimising long-term goals: practical approaches to novel potassium binder use in cardiorenal care
thumbnail
Congress Session
Strategies for managing hyperkalaemia in cardiorenal disease: a clinical dialogue defining a roadmap to improved outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources